Literature DB >> 21995968

Combining angiotensin receptor blockers with ACE inhibitors in elderly patients.

Shuchi Anand1, Manjula Kurella Tamura.   

Abstract

Entities:  

Year:  2011        PMID： 21995968      PMCID： PMC4077711          DOI： 10.1053/j.ajkd.2011.09.002

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  12 in total

1.  K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

2.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

Review 3.  Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.

Authors:  Christopher O Phillips; Amir Kashani; Dennis K Ko; Gary Francis; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2007-10-08

4.  Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.

Authors:  Sheldon W Tobe; Catherine M Clase; Peggy Gao; Matthew McQueen; Anja Grosshennig; Xingyu Wang; Koon K Teo; Salim Yusuf; Johannes F E Mann
Journal:  Circulation       Date:  2011-02-28       Impact factor: 29.690

5.  HFSA 2010 Comprehensive Heart Failure Practice Guideline.

Authors:  JoAnn Lindenfeld; Nancy M Albert; John P Boehmer; Sean P Collins; Justin A Ezekowitz; Michael M Givertz; Stuart D Katz; Marc Klapholz; Debra K Moser; Joseph G Rogers; Randall C Starling; William G Stevenson; W H Wilson Tang; John R Teerlink; Mary N Walsh
Journal:  J Card Fail       Date:  2010-06       Impact factor: 5.712

6.  The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis.

Authors:  Finlay A McAlister; Jianguo Zhang; Marcello Tonelli; Scott Klarenbach; Braden J Manns; Brenda R Hemmelgarn
Journal:  CMAJ       Date:  2011-03-21       Impact factor: 8.262

7.  Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.

Authors:  Andrea Kuenzli; Heiner C Bucher; Inder Anand; Gregory Arutiunov; Leo C Kum; Robert McKelvie; Rizwan Afzal; Michel White; Alain J Nordmann
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Epidemiology of chronic kidney disease in heart failure.

Authors:  Ali Ahmed; Ruth C Campbell
Journal:  Heart Fail Clin       Date:  2008-10       Impact factor: 3.179

9.  Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.

Authors:  Johannes F E Mann; Roland E Schmieder; Matthew McQueen; Leanne Dyal; Helmut Schumacher; Janice Pogue; Xingyu Wang; Aldo Maggioni; Andrzej Budaj; Suphachai Chaithiraphan; Kenneth Dickstein; Matyas Keltai; Kaj Metsärinne; Ali Oto; Alexander Parkhomenko; Leopoldo S Piegas; Tage L Svendsen; Koon K Teo; Salim Yusuf
Journal:  Lancet       Date:  2008-08-16       Impact factor: 79.321

10.  Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).

Authors:  Linda F Fried; William Duckworth; Jane Hongyuan Zhang; Theresa O'Connor; Mary Brophy; Nicholas Emanuele; Grant D Huang; Peter A McCullough; Paul M Palevsky; Stephen Seliger; Stuart R Warren; Peter Peduzzi
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 8.237
View more
  1 in total

Review 1.  EndMT Regulation by Small RNAs in Diabetes-Associated Fibrotic Conditions: Potential Link With Oxidative Stress.

Authors:  Roberta Giordo; Yusra M A Ahmed; Hilda Allam; Salah Abusnana; Lucia Pappalardo; Gheyath K Nasrallah; Arduino Aleksander Mangoni; Gianfranco Pintus
Journal:  Front Cell Dev Biol       Date:  2021-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.